| VERACYTE INC. DL-,001 |
| USA |
| Gesundheit |
| US92337F1075 / A1W7EA |
| 12V (Frankfurt) / VCYT (NASDAQ) |
| FRA:12V, ETR:12V, 12V:GR, NASDAQ:VCYT |
| - |
| https://www.veracyte.com/ |
|
Veracyte Inc. is a global diagnostics company specializing in advanced genomic tests that provide clinicians with precise insights to diagnose and treat cancer. Its portfolio features key products such as Afirma for thyroid cancer, Decipher Prostate ..
>Volltext.. |
| 3171.5 Mio. EUR |
| 2825.76 Mio. EUR |
| 464.66 Mio. EUR |
| 93.23 Mio. EUR |
| 75.49 Mio. EUR |
| 0.95 EUR |
| 33.74 Mio. EUR |
| 225.7 Mio. EUR |
| - |
| 7.82 |
| 9.47% |
| 149.36% |
| - |
| - |
| - |
| VERACYTE |
| 31.05.26 |
|
||||
|